Skip to main content
Premium Trial:

Request an Annual Quote

Waters Says Mass Spec Sales Fueled 12 Percent Revenue Increase in Q2

NEW YORK, July 27 (GenomeWeb News) - Waters today posted a 12 percent increase in second-quarter 2004 sales, along with a 42 percent increase in net income.

 

Waters reported sales of $260.5 million for the quarter, up from $232.0 million in sales for the second quarter of 2003. The company attributed the increase in part to its mass spectrometry business, which grew 11 percent during the quarter. The company said that shipments for chromatography systems, however, were below expectations for the second quarter because customer deliveries for the new AcQuity UPLC systems were shifted to August "to allow for additional manufacturing-related testing."

 

The company's net income was $59.8 million in the second quarter, up from $42.1 million in the year-ago period. Waters' earnings per diluted share for the second quarter were $.49, compared to $.33 for the comparable period in 2003.

 

The company's R&D costs for the quarter were $15.7 million, compared to $13.8 million in the second quarter of 2003.

 

Waters had $420 million in cash and cash equivalents as of July 3, 2004.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.